Product Information
STEGLATRO 5 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $11.4378 per EA under NDC 00006536306. Its NADAC has been published 418 times since Aug 22, 2018.
FDA first approved this application on Dec 19, 2017.
Strength
5 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006536306
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ERTUGLIFLOZIN PIDOLATEApproval Type
New Drug (NDA)
FDA Application
NDA209803FDA Approved
12/19/2017
On Market Since
12/19/2017
Price Statistics
The NADAC for STEGLATRO 5 MG TABLET has been published 418 times since Aug 22, 2018, and over the history we have for it it has risen 31.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4378 per EA |
|---|---|
| All-time high | $11.4535 (May 15, 2024) |
| All-time low | $8.5924 (Oct 17, 2018) |
| 52-week high | $11.4378 |
| 52-week low | $11.4185 |
| Median price | $10.3820 |
| Average price | $10.3599 |
| Largest weekly change | +5.0% (Jan 18, 2023) |
| Weeks tracked | 418 |
| Tracking since | Aug 22, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of STEGLATRO 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for STEGLATRO 5 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $11.4378 per EA (NDC 00006536306), effective Aug 19, 2026.
How has the price of STEGLATRO 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for STEGLATRO 5 MG TABLET has risen 31.8%. It has been tracked across 418 weekly CMS publications since Aug 22, 2018.
What are the highest and lowest recorded NADAC prices for STEGLATRO 5 MG TABLET?
Since Aug 22, 2018, the NADAC for STEGLATRO 5 MG TABLET has ranged from a low of $8.5924 (Oct 17, 2018) to a high of $11.4535 (May 15, 2024), with a median of $10.3820 per EA.
Are there cheaper alternatives to STEGLATRO 5 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, STEGLATRO 5 MG TABLET, is $10.9002 per EA — about 5% below STEGLATRO 5 MG TABLET.
Who manufactures STEGLATRO 5 MG TABLET?
STEGLATRO 5 MG TABLET (NDC 00006536306) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.